Department of Gastrointestinal Surgery, Xiangya Hospital of Central South University, Changsha, China.
Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China, Hunan Provincial People's Hospital, Changsha, Hunan, China.
BMJ Open. 2022 Apr 21;12(4):e053339. doi: 10.1136/bmjopen-2021-053339.
Anorectal melanoma (AM) is a rare but aggressive tumour with limited information in the existing literature. This study aimed to assess the effect of surgical treatment for AM and predict the prognosis of affected patients.
A retrospective cohort study.
Data of patients diagnosed with AM between 1975 and 2016 in the USA were collected from the Surveillance, Epidemiology, and End Results (SEER) database.
This study enrolled a total of 795 patients with AM from the SEER database and the validation cohort comprised 40 patients with AM enrolled from Chinese institutes.
Overall survival (OS) and AM-specific survival (AM-SS).
A total of 795 patients with AM diagnosed between 1975 and 2016 were enrolled in this study. Data over the past four decades showed a trend of increase in incidence rate. A nomogram based on a multivariate Cox regression model was generated to predict AM-SS. The C-index of the nomogram was 0.74 (95% CI 0.71 to 0.77) on internal verification. In the validation cohort, the C-index of the nomogram was 0.72 (95% CI 0.68 to 0.76). The results of propensity score matching (PSM) analysis showed that patients who underwent surgical treatment achieved significant survival (OS: log-rank=17.41, p<0.001; AM-SS: log-rank=14.55, p<0.001). Patients who underwent surgery were stratified into local and extended surgery subgroups. AM-SS and OS were also compared after PSM, but the results were not significantly different between the two surgery subgroups (all p>0.05).
The nomogram based on the analysis of SEER data showed good performance in predicting OS and AM-SS. Patients with AM can benefit from surgery; however, extensive surgery and appendectomy may not improve AM-SS or OS.
肛门直肠黑色素瘤(AM)是一种罕见但侵袭性很强的肿瘤,现有文献中相关信息有限。本研究旨在评估 AM 的手术治疗效果,并预测受影响患者的预后。
回顾性队列研究。
从美国监测、流行病学和最终结果(SEER)数据库中收集了 1975 年至 2016 年间诊断为 AM 的患者数据。
本研究共纳入了来自 SEER 数据库的 795 例 AM 患者,验证队列纳入了来自中国机构的 40 例 AM 患者。
总生存率(OS)和 AM 特异性生存率(AM-SS)。
本研究共纳入了 1975 年至 2016 年间诊断的 795 例 AM 患者。过去四十年的数据显示发病率呈上升趋势。基于多变量 Cox 回归模型生成了一个预测 AM-SS 的列线图。内部验证的列线图 C 指数为 0.74(95%CI 0.71 至 0.77)。在验证队列中,列线图的 C 指数为 0.72(95%CI 0.68 至 0.76)。倾向评分匹配(PSM)分析结果显示,接受手术治疗的患者生存显著改善(OS:log-rank=17.41,p<0.001;AM-SS:log-rank=14.55,p<0.001)。将接受手术的患者分为局部手术和扩大手术亚组。进行 PSM 后还比较了 AM-SS 和 OS,但两个手术亚组之间的结果无显著差异(均 p>0.05)。
基于 SEER 数据分析的列线图在预测 OS 和 AM-SS 方面表现良好。AM 患者可从手术中获益,但广泛手术和阑尾切除术可能不会改善 AM-SS 或 OS。